Value of blood pressure measurement earlier versus later in life to predict cardiovascular mortality

Abstract Hypertension is a potent risk factor for cardiovascular morbidity and mortality. High blood pressure (BP) correlates closely with all-cause The purpose of this study was to compare the value systolic earlier versus later in life predict In observation (OS) we prospectively recorded fatal events over up 19 years 1282 patients whom 570 had Metabolic Syndrome (MetS) at baseline. These participated health survey (HS) 15 prior OS BP measured both HS baseline OS. We found that increase mortality matched linear way but not case assessed (figure). A cox regression analysis revealed each millimeter mercury (mm Hg) increased death by 2% (HR = 1.02 [1.01–1.03], p<0.001). Applying stratification presence MetS, groups significant predictor (HRMetS [1.01–1.02], p<0.001 HRnoMetS contrast, as significantly associated during follow-up neither total population nor any subgroup 1.00 [0.99–1.01], p=0.652; HRMetS p=0.468 p=4.66). thus conclude better than life. Funding Acknowledgement Type funding sources: None.